AZURITY SOLUTIONS E-Z RX Trademark

Trademark Overview


On Thursday, March 7, 2024, a trademark application was filed for AZURITY SOLUTIONS E-Z RX with the United States Patent and Trademark Office. The USPTO has given the AZURITY SOLUTIONS E-Z RX trademark a serial number of 98438144. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 10, 2024. This trademark is owned by Azurity Pharmaceuticals, Inc.. The AZURITY SOLUTIONS E-Z RX trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Connecting qualified service providers with consumers in the nature of patient support services, namely, connecting patients with pharmacies for prescription drug access and medical cost management in the field of controlling medications costs; providing a discount savings program in the pharmaceutical field being administration of a program for enabling participants to obtain discounts on products

Providing medical information in the field of prescription drugs
azurity solutions e-z rx

General Information


Serial Number98438144
Word MarkAZURITY SOLUTIONS E-Z RX
Filing DateThursday, March 7, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Pseudo MarkAZURITY SOLUTIONS EASY PRESCRIPTION
Goods and ServicesConnecting qualified service providers with consumers in the nature of patient support services, namely, connecting patients with pharmacies for prescription drug access and medical cost management in the field of controlling medications costs; providing a discount savings program in the pharmaceutical field being administration of a program for enabling participants to obtain discounts on products
Goods and ServicesProviding medical information in the field of prescription drugs
NOT AVAILABLE"SOLUTIONS" and "RX"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 7, 2024
Primary Code035
First Use Anywhere DateFriday, March 25, 2022
First Use In Commerce DateFriday, March 25, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 7, 2024
Primary Code044
First Use Anywhere DateFriday, March 25, 2022
First Use In Commerce DateFriday, March 25, 2022

Trademark Owner History


Party NameAzurity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Party NameAzurity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024NEW APPLICATION ENTERED
Sunday, July 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 8, 2024ASSIGNED TO EXAMINER
Saturday, August 17, 2024NON-FINAL ACTION E-MAILED
Saturday, August 17, 2024NON-FINAL ACTION WRITTEN
Saturday, August 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 14, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, November 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 14, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, November 14, 2024EXAMINER'S AMENDMENT ENTERED